Dr. William DeRosa Discusses Nab-Paclitacel in Non-Small Cell Lung Cancer

11 Views

07/14/23

William T. DeRosa, DO, medical oncologist, Carol G. Simon Cancer Center at Morristown Memorial Hospital, discusses subset analyses from the phase III CA031 trial that examined nab-paclitaxel (Abraxane) in non-small cell lung cancer (NSCLC).

For more information about the CA031 trial and the FDA approval of nab-paclitaxel in lung cancer, visit http://www.onclive.com/web-exc....lusives/FDA-Approves